Visterra Inc.
Jacob VinayVikas Konakondla is an accomplished scientist with extensive experience in molecular biology and project management. Currently serving as an Associate Scientist at Visterra Inc., Jacob specializes in single-cell RNA sequencing technology. Prior roles include Senior Associate Scientist at Repertoire Immune Medicines, focusing on developing adoptive cell therapies for cancer, and Graduate Research Student at Brandeis University, where Jacob conducted research on circular RNAs in Drosophila. Jacob has also held significant management positions, such as Fly Facility Manager at the Centre for Cellular and Molecular Platforms and Drosophila Facility Incharge at the National Center for Biological Sciences, where responsibilities included strategic planning, operations management, and training research teams. Jacob's educational background encompasses a Master's degree in Cellular and Molecular Biology from Brandeis University, a Master's in Biotechnology from Bangalore University, and an MBA in Finance.
This person is not in the org chart
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.